Chapter/Section Purchase

1 Non-Invasive Hemostatic Closure Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Hemostatic Closure Devices
1.2 Non-Invasive Hemostatic Closure Devices Segment by Type
1.2.1 Global Non-Invasive Hemostatic Closure Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Closure Strips
1.2.3 Tissue Adhesive
1.2.4 Sutures
1.3 Non-Invasive Hemostatic Closure Devices Segment by Application
1.3.1 Global Non-Invasive Hemostatic Closure Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers
1.4 Global Non-Invasive Hemostatic Closure Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Hemostatic Closure Devices Revenue 2017-2028
1.4.2 Global Non-Invasive Hemostatic Closure Devices Sales 2017-2028
1.4.3 Non-Invasive Hemostatic Closure Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Non-Invasive Hemostatic Closure Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Hemostatic Closure Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Non-Invasive Hemostatic Closure Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Non-Invasive Hemostatic Closure Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Non-Invasive Hemostatic Closure Devices Manufacturing Sites, Area Served, Product Type
2.5 Non-Invasive Hemostatic Closure Devices Market Competitive Situation and Trends
2.5.1 Non-Invasive Hemostatic Closure Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-Invasive Hemostatic Closure Devices Players Market Share by Revenue
2.5.3 Global Non-Invasive Hemostatic Closure Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Hemostatic Closure Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Hemostatic Closure Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Non-Invasive Hemostatic Closure Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Non-Invasive Hemostatic Closure Devices Market Facts & Figures by Country
3.3.1 North America Non-Invasive Hemostatic Closure Devices Sales by Country
3.3.2 North America Non-Invasive Hemostatic Closure Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-Invasive Hemostatic Closure Devices Market Facts & Figures by Country
3.4.1 Europe Non-Invasive Hemostatic Closure Devices Sales by Country
3.4.2 Europe Non-Invasive Hemostatic Closure Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-Invasive Hemostatic Closure Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Non-Invasive Hemostatic Closure Devices Sales by Region
3.5.2 Asia Pacific Non-Invasive Hemostatic Closure Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Non-Invasive Hemostatic Closure Devices Market Facts & Figures by Country
3.6.1 Latin America Non-Invasive Hemostatic Closure Devices Sales by Country
3.6.2 Latin America Non-Invasive Hemostatic Closure Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-Invasive Hemostatic Closure Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-Invasive Hemostatic Closure Devices Sales by Country
3.7.2 Middle East and Africa Non-Invasive Hemostatic Closure Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-Invasive Hemostatic Closure Devices Historic Market Analysis by Type
4.1 Global Non-Invasive Hemostatic Closure Devices Sales Market Share by Type (2017-2022)
4.2 Global Non-Invasive Hemostatic Closure Devices Revenue Market Share by Type (2017-2022)
4.3 Global Non-Invasive Hemostatic Closure Devices Price by Type (2017-2022)
5 Global Non-Invasive Hemostatic Closure Devices Historic Market Analysis by Application
5.1 Global Non-Invasive Hemostatic Closure Devices Sales Market Share by Application (2017-2022)
5.2 Global Non-Invasive Hemostatic Closure Devices Revenue Market Share by Application (2017-2022)
5.3 Global Non-Invasive Hemostatic Closure Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Corporation Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Medline Non-Invasive Hemostatic Closure Devices Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 3M Healthcare
6.2.1 3M Healthcare Corporation Information
6.2.2 3M Healthcare Description and Business Overview
6.2.3 3M Healthcare Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 3M Healthcare Non-Invasive Hemostatic Closure Devices Product Portfolio
6.2.5 3M Healthcare Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Medtronic Non-Invasive Hemostatic Closure Devices Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Ethicon (Johnson & Johnson)
6.4.1 Ethicon (Johnson & Johnson) Corporation Information
6.4.2 Ethicon (Johnson & Johnson) Description and Business Overview
6.4.3 Ethicon (Johnson & Johnson) Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ethicon (Johnson & Johnson) Non-Invasive Hemostatic Closure Devices Product Portfolio
6.4.5 Ethicon (Johnson & Johnson) Recent Developments/Updates
6.5 Biotronik
6.5.1 Biotronik Corporation Information
6.5.2 Biotronik Description and Business Overview
6.5.3 Biotronik Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Biotronik Non-Invasive Hemostatic Closure Devices Product Portfolio
6.5.5 Biotronik Recent Developments/Updates
6.6 Starch Medical
6.6.1 Starch Medical Corporation Information
6.6.2 Starch Medical Description and Business Overview
6.6.3 Starch Medical Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Starch Medical Non-Invasive Hemostatic Closure Devices Product Portfolio
6.6.5 Starch Medical Recent Developments/Updates
6.7 Olympus
6.6.1 Olympus Corporation Information
6.6.2 Olympus Description and Business Overview
6.6.3 Olympus Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Olympus Non-Invasive Hemostatic Closure Devices Product Portfolio
6.7.5 Olympus Recent Developments/Updates
6.8 Teleflex
6.8.1 Teleflex Corporation Information
6.8.2 Teleflex Description and Business Overview
6.8.3 Teleflex Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Teleflex Non-Invasive Hemostatic Closure Devices Product Portfolio
6.8.5 Teleflex Recent Developments/Updates
6.9 BSN medical
6.9.1 BSN medical Corporation Information
6.9.2 BSN medical Description and Business Overview
6.9.3 BSN medical Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 BSN medical Non-Invasive Hemostatic Closure Devices Product Portfolio
6.9.5 BSN medical Recent Developments/Updates
6.10 Baxter International
6.10.1 Baxter International Corporation Information
6.10.2 Baxter International Description and Business Overview
6.10.3 Baxter International Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Baxter International Non-Invasive Hemostatic Closure Devices Product Portfolio
6.10.5 Baxter International Recent Developments/Updates
6.11 Radi Medical Systems
6.11.1 Radi Medical Systems Corporation Information
6.11.2 Radi Medical Systems Non-Invasive Hemostatic Closure Devices Description and Business Overview
6.11.3 Radi Medical Systems Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Radi Medical Systems Non-Invasive Hemostatic Closure Devices Product Portfolio
6.11.5 Radi Medical Systems Recent Developments/Updates
6.12 Abbott Vascular
6.12.1 Abbott Vascular Corporation Information
6.12.2 Abbott Vascular Non-Invasive Hemostatic Closure Devices Description and Business Overview
6.12.3 Abbott Vascular Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Abbott Vascular Non-Invasive Hemostatic Closure Devices Product Portfolio
6.12.5 Abbott Vascular Recent Developments/Updates
6.13 NeatStitch
6.13.1 NeatStitch Corporation Information
6.13.2 NeatStitch Non-Invasive Hemostatic Closure Devices Description and Business Overview
6.13.3 NeatStitch Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 NeatStitch Non-Invasive Hemostatic Closure Devices Product Portfolio
6.13.5 NeatStitch Recent Developments/Updates
6.14 Derma Sciences
6.14.1 Derma Sciences Corporation Information
6.14.2 Derma Sciences Non-Invasive Hemostatic Closure Devices Description and Business Overview
6.14.3 Derma Sciences Non-Invasive Hemostatic Closure Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Derma Sciences Non-Invasive Hemostatic Closure Devices Product Portfolio
6.14.5 Derma Sciences Recent Developments/Updates
7 Non-Invasive Hemostatic Closure Devices Manufacturing Cost Analysis
7.1 Non-Invasive Hemostatic Closure Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-Invasive Hemostatic Closure Devices
7.4 Non-Invasive Hemostatic Closure Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-Invasive Hemostatic Closure Devices Distributors List
8.3 Non-Invasive Hemostatic Closure Devices Customers
9 Non-Invasive Hemostatic Closure Devices Market Dynamics
9.1 Non-Invasive Hemostatic Closure Devices Industry Trends
9.2 Non-Invasive Hemostatic Closure Devices Market Drivers
9.3 Non-Invasive Hemostatic Closure Devices Market Challenges
9.4 Non-Invasive Hemostatic Closure Devices Market Restraints
10 Global Market Forecast
10.1 Non-Invasive Hemostatic Closure Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-Invasive Hemostatic Closure Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Non-Invasive Hemostatic Closure Devices by Type (2023-2028)
10.2 Non-Invasive Hemostatic Closure Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-Invasive Hemostatic Closure Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Non-Invasive Hemostatic Closure Devices by Application (2023-2028)
10.3 Non-Invasive Hemostatic Closure Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-Invasive Hemostatic Closure Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Non-Invasive Hemostatic Closure Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer